May 13, 2021 / 02:15PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Okay. Good morning, and welcome to the last day of the Bank of America Healthcare Conference. We're in Virtual Vegas. My name is Geoff Meacham. I'm the Senior Biopharma Analyst here at BofA. I have Greg Harrison from my team as well. And we're thrilled to have Vertex Pharmaceuticals for our next session. Speaking of Vertex, we have CFO, Charlie Wagner. Charlie, thanks for joining us.
Charles F. Wagner - Vertex Pharmaceuticals Incorporated - Executive VP & CFO
Yes, Geoff, thank you. Appreciate it, and happy to join the conference today.
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Yes. So let's do a Q&A, but do you want to kick it off with just something high level post the quarter and to set the stage and then we have some questions.
Charles F. Wagner - Vertex Pharmaceuticals Incorporated - Executive VP & CFO
Yes, absolutely. Listen, 2021
Vertex Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers